GB0208608D0 - Composition - Google Patents

Composition

Info

Publication number
GB0208608D0
GB0208608D0 GBGB0208608.0A GB0208608A GB0208608D0 GB 0208608 D0 GB0208608 D0 GB 0208608D0 GB 0208608 A GB0208608 A GB 0208608A GB 0208608 D0 GB0208608 D0 GB 0208608D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0208608.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0208608.0A priority Critical patent/GB0208608D0/en
Publication of GB0208608D0 publication Critical patent/GB0208608D0/en
Priority to JP2003585695A priority patent/JP2005530733A/ja
Priority to PCT/GB2003/001542 priority patent/WO2003088943A1/en
Priority to CA002481467A priority patent/CA2481467A1/en
Priority to US10/511,042 priority patent/US20050244340A1/en
Priority to EP03712461A priority patent/EP1494644A1/en
Priority to MXPA04010080A priority patent/MXPA04010080A/es
Priority to CN038137194A priority patent/CN1658839A/zh
Priority to KR10-2004-7016302A priority patent/KR20040099436A/ko
Priority to AU2003217073A priority patent/AU2003217073A1/en
Priority to BR0309114-7A priority patent/BR0309114A/pt
Priority to RU2004130439/15A priority patent/RU2004130439A/ru
Priority to PL03373294A priority patent/PL373294A1/xx
Priority to TW092108394A priority patent/TW200404008A/zh
Priority to ARP030101280A priority patent/AR039409A1/es
Priority to IL16442004A priority patent/IL164420A0/xx
Priority to IS7500A priority patent/IS7500A/is
Priority to ZA200408245A priority patent/ZA200408245B/xx
Priority to NO20044497A priority patent/NO20044497L/no
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB0208608.0A 2002-04-13 2002-04-13 Composition Ceased GB0208608D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB0208608.0A GB0208608D0 (en) 2002-04-13 2002-04-13 Composition
PL03373294A PL373294A1 (en) 2002-04-13 2003-04-10 Dry powder compositions
KR10-2004-7016302A KR20040099436A (ko) 2002-04-13 2003-04-10 건조 분말 조성물
BR0309114-7A BR0309114A (pt) 2002-04-13 2003-04-10 Uso de carboidratos derivados particulados em composições farmacêuticas em pó seco, composição farmacêutica em pó seco para terapia de inalação, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, e, embalagem de medicamento
CA002481467A CA2481467A1 (en) 2002-04-13 2003-04-10 Dry powder compositions
US10/511,042 US20050244340A1 (en) 2002-04-13 2003-04-10 Dry powder compositions
EP03712461A EP1494644A1 (en) 2002-04-13 2003-04-10 Dry powder compositions
MXPA04010080A MXPA04010080A (es) 2002-04-13 2003-04-10 Composiciones de polvo seco.
CN038137194A CN1658839A (zh) 2002-04-13 2003-04-10 干粉组合物
JP2003585695A JP2005530733A (ja) 2002-04-13 2003-04-10 乾燥粉末組成物
AU2003217073A AU2003217073A1 (en) 2002-04-13 2003-04-10 Dry powder compositions
PCT/GB2003/001542 WO2003088943A1 (en) 2002-04-13 2003-04-10 Dry powder compositions
RU2004130439/15A RU2004130439A (ru) 2002-04-13 2003-04-10 Сухие порошковые композиции
ARP030101280A AR039409A1 (es) 2002-04-13 2003-04-11 Composicion farmaceutica en polvo seco para inhalacion, fabricacion y uso.
TW092108394A TW200404008A (en) 2002-04-13 2003-04-11 Composition
IL16442004A IL164420A0 (en) 2002-04-13 2004-10-05 Dry powder composition
IS7500A IS7500A (is) 2002-04-13 2004-10-11 thurrdufts samsetningar
ZA200408245A ZA200408245B (en) 2002-04-13 2004-10-12 Dry powder compositions
NO20044497A NO20044497L (no) 2002-04-13 2004-10-21 Torr pulver sammensetninger

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0208608.0A GB0208608D0 (en) 2002-04-13 2002-04-13 Composition

Publications (1)

Publication Number Publication Date
GB0208608D0 true GB0208608D0 (en) 2002-05-22

Family

ID=9934855

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0208608.0A Ceased GB0208608D0 (en) 2002-04-13 2002-04-13 Composition

Country Status (19)

Country Link
US (1) US20050244340A1 (enExample)
EP (1) EP1494644A1 (enExample)
JP (1) JP2005530733A (enExample)
KR (1) KR20040099436A (enExample)
CN (1) CN1658839A (enExample)
AR (1) AR039409A1 (enExample)
AU (1) AU2003217073A1 (enExample)
BR (1) BR0309114A (enExample)
CA (1) CA2481467A1 (enExample)
GB (1) GB0208608D0 (enExample)
IL (1) IL164420A0 (enExample)
IS (1) IS7500A (enExample)
MX (1) MXPA04010080A (enExample)
NO (1) NO20044497L (enExample)
PL (1) PL373294A1 (enExample)
RU (1) RU2004130439A (enExample)
TW (1) TW200404008A (enExample)
WO (1) WO2003088943A1 (enExample)
ZA (1) ZA200408245B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005507881A (ja) 2001-09-17 2005-03-24 グラクソ　グループ　リミテッド 乾燥粉末医薬製剤
SE526509C2 (sv) * 2003-06-19 2005-09-27 Microdrug Ag Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
JP2009513529A (ja) * 2003-07-11 2009-04-02 グラクソ グループ リミテッド ステアリン酸マグネシウムを含む医薬製剤
EP1643974A1 (en) * 2003-07-11 2006-04-12 Glaxo Group Limited Inhalable pharmaceutical formulations comprising a sugar ester
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
WO2006066907A1 (en) * 2004-12-21 2006-06-29 Glaxo Group Limited Pharmaceutical formulations
NZ556709A (en) * 2005-02-10 2009-09-25 Glaxo Group Ltd Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
JP2009545579A (ja) 2006-08-01 2009-12-24 グラクソ グループ リミテッド ピラゾロ［３，４−ｂ］ピリジン化合物、及びｐｄｅ４阻害薬としてのその使用
GB0921075D0 (en) * 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
CN105324107A (zh) * 2013-04-29 2016-02-10 赛诺菲股份有限公司 可吸入药用组合物和含有该药用组合物的吸入器装置
AU2015296024A1 (en) * 2014-08-01 2017-03-23 Luxena Pharmaceuticals, Inc. Palonosetron formulations and uses thereof
PT109030B (pt) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
CN110237373B (zh) * 2018-03-08 2023-06-02 润生药业有限公司 一种生产用于联合用药的药物载体的装置及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8007911A (pt) * 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
SE448277B (sv) * 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
FI88112C (fi) * 1985-07-30 1993-04-13 Glaxo Group Ltd Anordning foer administrering av laekemedel till patienter
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
JPH04220268A (ja) * 1990-12-19 1992-08-11 Olympus Optical Co Ltd バルーンカテーテル
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
DE69809746T2 (de) * 1997-07-03 2004-09-30 Elan Drug Delivery Ltd., Ruddington Modifiziere glykoside, modifizierte glyckoside enthaltende zusammensetzungen und verfahren zu ihrer herstellung
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
HU226164B1 (en) * 1998-11-13 2008-05-28 Jagotec Ag Use of magnesium stearate in dry powder compositions suitable for inhalation and compositions suitable for inhalation
GB9916316D0 (en) * 1999-07-12 1999-09-15 Quadrant Holdings Cambridge Dry powder compositions
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0020616D0 (en) * 2000-08-21 2000-10-11 Quadrant Holdings Cambridge Particulates
WO2002043750A2 (en) * 2000-12-01 2002-06-06 Battelle Memorial Institute Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CN1658839A (zh) 2005-08-24
US20050244340A1 (en) 2005-11-03
RU2004130439A (ru) 2005-06-10
KR20040099436A (ko) 2004-11-26
IL164420A0 (en) 2005-12-18
IS7500A (is) 2004-10-11
CA2481467A1 (en) 2003-10-30
WO2003088943A1 (en) 2003-10-30
AR039409A1 (es) 2005-02-16
AU2003217073A1 (en) 2003-11-03
EP1494644A1 (en) 2005-01-12
BR0309114A (pt) 2005-02-01
NO20044497L (no) 2004-11-15
ZA200408245B (en) 2007-03-28
TW200404008A (en) 2004-03-16
JP2005530733A (ja) 2005-10-13
PL373294A1 (en) 2005-08-22
MXPA04010080A (es) 2004-12-13

Similar Documents

Publication Publication Date Title
GB0220467D0 (en) Composition
GB0213638D0 (en) Composition
GB0212062D0 (en) Jetable compositions
IL165372A0 (en) Immunodenic compositions
GB0224415D0 (en) Compositions
GB0318894D0 (en) Composition
GB0208609D0 (en) Compositions
GB0203421D0 (en) Composition
GB0227244D0 (en) Composition
GB0208608D0 (en) Composition
GB0203280D0 (en) Anti-glycolytic composition
GB0203296D0 (en) Novel composition
GB0221894D0 (en) Compositions
AU2003269904A8 (en) Antigen-polymer compositions
GB0203395D0 (en) Compositions
GB0211924D0 (en) Composition
GB0203396D0 (en) Compositions
GB0218241D0 (en) Composition
GB0318152D0 (en) Composition
GB0217366D0 (en) Compositions
EP1495751A4 (en) hair dye
GB0213767D0 (en) Composition
GB0229286D0 (en) Composition
GB2394114B (en) Compositions
GB0205786D0 (en) Novel Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)